US Patent 10927136 Phosphorus prodrugs of pyrazolo-substituted pyrimidine sGC stimulators
Patent 10927136 was granted and assigned to Cyclerion Therapeutics on February, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+214 characters)
Article
Patent abstract
The present patent application discloses the compounds according to Formula (I) shown below, or pharmaceutically acceptable salts thereof wherein JB, n, R1, R2, R3, R4, R5, m and X as defined herein.
Edits on 9 Oct, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Ara Mermerian0
Glen Robert Rennie0
James Edward Sheppeck0
Paul Allan Renhowe0
Rajesh R. Iyengar0
Takashi Nakai0
Timothy Claude Barden0
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 4 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
109271360
Date of Patent
February 23, 2021
0Patent Application Number
163152100
Date Filed
July 6, 2017
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 10 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10927136 Phosphorus prodrugs of pyrazolo-substituted pyrimidine sGC stimulators
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10927136
Date of patent
February 23, 2021
Patent application number
16315210
Date Filed
July 6, 2017
Patent primary examiner
Find more entities like US Patent 10927136 Phosphorus prodrugs of pyrazolo-substituted pyrimidine sGC stimulators
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.